Utility of commercial systems for identification of Burkholderia cepacia complex from cystic fibrosis sputum culture

被引:53
作者
Shelly, DB
Spilker, T
Gracely, EJ
Coenye, T
Vandamme, P
LiPuma, JJ
机构
[1] Univ Michigan, Sch Med, Dept Pediat & Communicable Dis, Ann Arbor, MI 48109 USA
[2] Childrens Hosp Philadelphia, Clin Microbiol Lab, Philadelphia, PA 19104 USA
[3] MCP Hahnemann Univ, Dept Community & Prevent Med, Philadelphia, PA 19129 USA
[4] State Univ Ghent, Microbiol Lab, B-9000 Ghent, Belgium
关键词
D O I
10.1128/JCM.38.8.3112-3115.2000
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Performances of several commercial test systems were reviewed to determine their relative levels of accuracy in identifying Burkholderia cepacia complex isolates recovered from cystic fibrosis sputum culture. Positive predictive values ranged from 71 to 98%; negative predictive values ranged from 50 to 82%, All systems misidentified S. cepacia complex. The species most frequently misidentified as B. cepacia was Burkholderia gladioli, These data support the results of previous studies that recommend confirmatory testing, including the use of DNA-based methods, for sputum culture isolates presumptively identified as B. cepacia.
引用
收藏
页码:3112 / 3115
页数:4
相关论文
共 14 条
[1]   XANTHOMONAS-MALTOPHILIA MISIDENTIFIED AS PSEUDOMONAS-CEPACIA IN CULTURES OF SPUTUM FROM PATIENTS WITH CYSTIC-FIBROSIS - A DIAGNOSTIC PITFALL WITH MAJOR CLINICAL IMPLICATIONS [J].
BURDGE, DR ;
NOBLE, MA ;
CAMPBELL, ME ;
KRELL, VL ;
SPEERT, DP .
CLINICAL INFECTIOUS DISEASES, 1995, 20 (02) :445-448
[2]   COMPARATIVE-EVALUATION OF SELECTIVE MEDIA FOR ISOLATION OF PSEUDOMONAS-CEPACIA FROM CYSTIC-FIBROSIS PATIENTS AND ENVIRONMENTAL SOURCES [J].
CARSON, LA ;
TABLAN, OC ;
CUSICK, LB ;
JARVIS, WR ;
FAVERO, MS ;
BLAND, LA .
JOURNAL OF CLINICAL MICROBIOLOGY, 1988, 26 (10) :2096-2100
[3]   Description of Pandoraea gen. nov with Pandoraea apista sp nov., Pandoraea pulmonicola sp nov., Pandoraea pnomenusa sp nov., Pandoraea sputorum sp nov and Pandoraea norimbergensis comb. nov. [J].
Coenye, T ;
Falsen, E ;
Hoste, B ;
Ohlén, M ;
Goris, J ;
Govan, JRW ;
Gillis, M ;
Vandamme, P .
INTERNATIONAL JOURNAL OF SYSTEMATIC AND EVOLUTIONARY MICROBIOLOGY, 2000, 50 :887-899
[4]  
Gilligan Peter H., 1995, P509
[5]   Identification of Burkholderia cepacia isolates from patients with cystic fibrosis and use of a simple new selective medium [J].
Henry, DA ;
Campbell, ME ;
LiPuma, JJ ;
Speert, DP .
JOURNAL OF CLINICAL MICROBIOLOGY, 1997, 35 (03) :614-619
[6]   Accuracy of four commercial systems for identification of Burkholderia cepacia and other gram-negative nonfermenting bacilli recovered from patients with cystic fibrosis [J].
Kiska, DL ;
Kerr, A ;
Jones, M ;
Caracciolo, JA ;
Eskridge, B ;
Jordan, M ;
Miller, S ;
Hughes, D ;
King, N ;
Gilligan, PH .
JOURNAL OF CLINICAL MICROBIOLOGY, 1996, 34 (04) :886-891
[7]  
LiPuma J J, 1998, Curr Opin Pulm Med, V4, P337, DOI 10.1097/00063198-199811000-00005
[8]   Development of rRNA-based PCR assays for identification of Burkholderia cepacia complex isolates recovered from cystic fibrosis patients [J].
LiPuma, JJ ;
Dulaney, BJ ;
McMenamin, JD ;
Whitby, PW ;
Stull, TL ;
Coenye, T ;
Vandamme, P .
JOURNAL OF CLINICAL MICROBIOLOGY, 1999, 37 (10) :3167-3170
[9]   Burkholderia cepacia - Management issues and new insights [J].
LiPuma, JJ .
CLINICS IN CHEST MEDICINE, 1998, 19 (03) :473-+
[10]   Misidentification of Burkholderia cepacia in US cystic fibrosis treatment centers -: An analysis of 1,051 recent sputum isolates [J].
McMenamin, JD ;
Zaccone, TM ;
Coenye, T ;
Vandamme, P ;
LiPuma, JJ .
CHEST, 2000, 117 (06) :1661-1665